AI marketing ROI

AI Marketing ROI is one of the fastest-moving categories in 2026 technology, with foundation-model capabilities advancing on 3-6 month cycles and enterprise deployment patterns consolidating around a handful of HIPAA-ready and BAA-capable platforms. The FDA’s AI/ML-enabled medical device list now exceeds 1,000 authorizations and roughly doubles every two years. McKinsey’s 2024 analysis projected $150B-$260B in annual U.S. Healthcare productivity from generative AI, concentrated in administrative and back-office categories in the near term.

This archive collects 210 Digital Marketing’s coverage of AI Marketing ROI — what it is, how it deploys responsibly, which vendors and platforms are credible (Microsoft, Google, OpenAI, Anthropic, Epic’s embedded tooling, Salesforce Health Cloud with Einstein), what the peer-reviewed evidence base actually supports, and the governance discipline that turns AI Marketing ROI capability into durable organizational advantage. Articles reference primary regulatory sources (FDA, HHS OCR, ONC) and top-tier journals (Nature Medicine, JAMA, NEJM, BMJ) rather than vendor-curated benchmarks.

Written for technology and clinical leaders scoping AI Marketing ROI strategy — CIOs, CMIOs, chief digital officers, compliance officers, and operational leaders evaluating vendor partnerships. If you are trying to separate signal from vendor marketing, this tag archive is filtered for peer-reviewed and regulatory evidence rather than promotional content. Browse for AI Marketing ROI, AI Marketing ROI strategy, AI Marketing ROI deployment, and the operator-grade evidence base leaders actually use.